LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism

Murine ES cells can be maintained as a pluripotent, self-renewing population by LIF/STAT3-dependent signaling. The downstream effectors of this pathway have not been previously defined. In this report, we identify a key target of the LIF self-renewal pathway by showing that STAT3 directly regulates the expression of the Myc transcription factor. Murine ES cells express elevated levels of Myc and following LIF withdrawal, Myc mRNA levels collapse and Myc protein becomes phosphorylated on threonine 58 (T58), triggering its GSK3β dependent degradation. Maintained expression of stable Myc (T58A) renders self-renewal and maintenance of pluripotency independent of LIF. By contrast, expression of a dominant negative form of Myc antagonizes self-renewal and promotes differentiation. Transcriptional control by STAT3 and suppression of T58 phosphorylation are crucial for regulation of Myc activity in ES cells and therefore in promoting self-renewal. Together, our results establish a mechanism for how LIF and STAT3 regulate ES cell self-renewal and pluripotency.

[1]  M. Welham,et al.  Regulation of Embryonic Stem Cell Self-renewal by Phosphoinositide 3-Kinase-dependent Signaling* , 2004, Journal of Biological Chemistry.

[2]  Ana D. Lopez,et al.  Maintenance of Pluripotency in Human Embryonic Stem Cells Is STAT3 Independent , 2004, Stem cells.

[3]  S. McMahon,et al.  Analysis of genomic targets reveals complex functions of MYC , 2004, Nature Reviews Cancer.

[4]  I. Matsumura,et al.  Roles for c-Myc in Self-renewal of Hematopoietic Stem Cells* , 2004, Journal of Biological Chemistry.

[5]  B. Clurman,et al.  The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Jing Wang,et al.  BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Joseph R. Nevins,et al.  A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells , 2004, Nature Cell Biology.

[8]  D. Rowitch,et al.  Hedgehog and PI-3 kinase signaling converge on Nmyc1 to promote cell cycle progression in cerebellar neuronal precursors , 2004, Development.

[9]  P. Greengard,et al.  Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor , 2004, Nature Medicine.

[10]  Y. Mishina,et al.  BMP 4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways , 2004 .

[11]  Ying Qi,et al.  Phosphorylation by Glycogen Synthase Kinase-3 Controls c-Myc Proteolysis and Subnuclear Localization* , 2003, Journal of Biological Chemistry.

[12]  J. Nichols,et al.  BMP Induction of Id Proteins Suppresses Differentiation and Sustains Embryonic Stem Cell Self-Renewal in Collaboration with STAT3 , 2003, Cell.

[13]  T. Graeber,et al.  Myc-driven murine prostate cancer shares molecular features with human prostate tumors. , 2003, Cancer cell.

[14]  F. Watt,et al.  Evidence that Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment , 2003, Development.

[15]  H. Schöler,et al.  Nanog A New Recruit to the Embryonic Stem Cell Orchestra , 2003, Cell.

[16]  M. Murakami,et al.  The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells , 2003, Cell.

[17]  J. Nichols,et al.  Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells , 2003, Cell.

[18]  I. Weissman,et al.  A role for Wnt signalling in self-renewal of haematopoietic stem cells , 2003, Nature.

[19]  Andrea Cocito,et al.  Genomic targets of the human c-Myc protein. , 2003, Genes & development.

[20]  B. Edgar,et al.  Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. , 2003, Genes & development.

[21]  Duncan Walker,et al.  Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities , 2002, Oncogene.

[22]  R. Eisenman,et al.  N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. , 2002, Genes & development.

[23]  T. Yokota,et al.  CD9 is associated with leukemia inhibitory factor-mediated maintenance of embryonic stem cells. , 2002, Molecular biology of the cell.

[24]  L. Penn,et al.  The myc oncogene: MarvelouslY Complex. , 2002, Advances in cancer research.

[25]  T. Yokota,et al.  CD 9 Is Associated with Leukemia Inhibitory Factor-mediated Maintenance of Embryonic Stem Cells , 2002 .

[26]  A. Dierich,et al.  The Ribosomal S6 Kinases, cAMP-responsive Element-binding, and STAT3 Proteins Are Regulated by Different Leukemia Inhibitory Factor Signaling Pathways in Mouse Embryonic Stem Cells* , 2001, The Journal of Biological Chemistry.

[27]  S. Schreiner,et al.  MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation. , 2001, Cancer research.

[28]  T. Yeatman,et al.  Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Roop,et al.  Deregulated expression of c-Myc depletes epidermal stem cells , 2001, Nature Genetics.

[30]  白銀 隆宏.  Synergistic Roles for Pim-1 and c-Myc in STAT 3 -Mediated Cell Cycle Progression and Antiapoptosis , 2001 .

[31]  J. Nichols,et al.  Embryonic stem cells and transgenic mice ubiquitously expressing a tau-tagged green fluorescent protein. , 2000, Developmental biology.

[32]  Y Taya,et al.  Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. , 2000, Genes & development.

[33]  M. Cole,et al.  The c-Myc Transactivation Domain Is a Direct Modulator of Apoptotic versus Proliferative Signals , 2000, Molecular and Cellular Biology.

[34]  F. Alt,et al.  N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. , 2000, Genes & development.

[35]  J. Miyazaki,et al.  Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells , 2000, Nature Genetics.

[36]  R. DePinho,et al.  Essential role for Max in early embryonic growth and development. , 2000, Genes & development.

[37]  T. Hirano,et al.  Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. , 1999, Immunity.

[38]  M. Katsuki,et al.  STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells , 1999, The EMBO journal.

[39]  G. Evan,et al.  Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. , 1999, Molecular cell.

[40]  T. Hirano,et al.  Stat3 Is Required for the Gp130-mediated Full Activation of the C-myc Gene , 1999 .

[41]  Orchestra , 1998 .

[42]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[43]  M. Ikawa,et al.  Generating green fluorescent mice by germline transmission of green fluorescent ES cells , 1998, Mechanisms of Development.

[44]  Keigo Nishida,et al.  Gab1 Acts as an Adapter Molecule Linking the Cytokine Receptor gp130 to ERK Mitogen-Activated Protein Kinase , 1998, Molecular and Cellular Biology.

[45]  A. Smith,et al.  Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. , 1998, Genes & development.

[46]  G. Hannon,et al.  Myc activates telomerase. , 1998, Genes & development.

[47]  T. Hirano,et al.  STAT 3 Is Required for the gp 130-mediated Full Activation of the c-myc Gene , 1998 .

[48]  J. Darnell.  STATs and gene regulation. , 1997, Science.

[49]  Tomoko Nakanishi,et al.  ‘Green mice’ as a source of ubiquitous green cells , 1997, FEBS letters.

[50]  C. Dang,et al.  Max and inhibitory c-Myc mutants induce erythroid differentiation and resistance to apoptosis in human myeloid leukemia cells , 1997, Oncogene.

[51]  B. Hoffman,et al.  The proto-oncogene c-myc blocks myeloid differentiation independently of its target gene ornithine decarboxylase. , 1996, Blood.

[52]  A. Grzeschiczek,et al.  Expression of a rlf/L-myc minigene inhibits differentiation of embryonic stem cells and embroid body formation. , 1994, Oncogene.

[53]  G. Yancopoulos,et al.  Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors. , 1994, The Journal of biological chemistry.

[54]  A. Bradley,et al.  A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. , 1993, Genes & development.

[55]  A. Perkins,et al.  Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. , 1992, Genes & development.

[56]  Didier Picard,et al.  Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells , 1989, Nature.

[57]  J. Bishop,et al.  Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. , 1989, Genes & development.

[58]  R Kemler,et al.  The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. , 1985, Journal of embryology and experimental morphology.